title: Mortality following hip fracture surgery in patients with recent myocardial infarction.
abstract: BACKGROUND
  In an elective setting, surgery is best avoided for at least 6 months following myocardial infarction. However, in the presence of a femoral neck fracture, this would most probably lead to significant complications in relation to prolonged immobilisation. There is no published mortality data for patients undergoing surgery for hip fracture following a recent myocardial infarction. The aim of this retrospective study was to assess the mortality of hip fracture patients with a recent myocardial infarction that have undergone surgery at our institution.
  
  
  METHODS
  Between January 2003 and October 2005, 2270 patients were admitted to our unit with a proximal femoral fracture. Of these, 11 patients were found to have a recent myocardial infarction.
  
  
  RESULTS
  Of these 11 patients, 8 were female. The average age was 78.2 years (range, 59-90 years). Average delay from the time of infarction to operation was 11.2 days (range, 3-23 days). Mortality at 1 and 6 months was 45.4% and 63.5%, respectively.
  
  
  CONCLUSIONS
  This is much higher than the overall reported mortality following proximal femur fracture. This information may be useful when planning future peri-operative care and discussing overall prognosis with patients and their relatives.
authors: Department of Orthopaedics, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK. baskaran.komarasamy@gmail.com
authors: Baskaran
authors: B
authors: Komarasamy
authors: Mark C
authors: MC
authors: Forster
authors: Colin N
authors: CN
authors: Esler
authors: William M
authors: WM
authors: Harper
authors: Andrew P
authors: AP
authors: Hall
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000758:Anesthesia / Q000379:methods; D005260:Female; D005265:Femoral Neck Fractures / Q000150:complications / Q000401:mortality* / Q000601:surgery*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007430:Intraoperative Care / Q000379:methods; D007431:Intraoperative Complications / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000401:mortality*; D015996:Survival Rate
chemical_list: D000319:Adrenergic beta-Antagonists; D005343:Fibrinolytic Agents
references: BMJ. 1993 Nov 13;307(6914):1248-50
references: 8166806
references: Clin Cardiol. 2000 Nov;23(11):831-6
references: 11097130
references: BMJ. 1997 Oct 11;315(7113):909-12
references: 9361539
references: J Bone Joint Surg Br. 1996 Jan;78(1):115-8
references: 8898140
references: J Bone Joint Surg Br. 1992 Mar;74(2):199-202
references: 1544951
references: Cochrane Database Syst Rev. 2000;(2):CD000337
references: 10796345
references: J Bone Joint Surg Br. 1989 Aug;71(4):619-23
references: 2670950
references: Anesthesiology. 1983 Dec;59(6):499-505
references: 6650905
references: Injury. 2002 Jan;33(1):13-7
references: 11879826
references: Br J Anaesth. 2005 Jan;94(1):24-9
references: 15516350
references: J Bone Joint Surg Br. 2001 Apr;83(3):414-8
references: 11341430
references: BMJ. 2005 Dec 10;331(7529):1374
references: 16299013
references: J Bone Joint Surg Br. 1992 Mar;74(2):203-5
references: 1544952
references: N Engl J Med. 1999 Jul 22;341(4):217-25
references: 10413733
references: BMJ. 1995 Apr 8;310(6984):904-8
references: 7719180
references: N Engl J Med. 1993 Sep 2;329(10):673-82
references: 8204123
references: Br J Anaesth. 2002 Jan;88(1):65-71
references: 11881887
references: Cardiology. 1998 Mar;89(3):216-21
references: 9570437